> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance on Donor Screening to Reduce Zika Virus
- URL: https://www.fdaweb.com/guidance-on-donor-screening-to-reduce-zika-virus/
- Published: 2016-02-19T12:00:00.000Z
- Updated: 2026-09-15T02:37:27.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134827

*Federal Register* Notice: FDA is making available a guidance: *Recommendations for Donor Screening, Deferral, and Product Management to Reduce the Risk of Transfusion-Transmission of Zika Virus.* The document provides blood establishments that collect blood and blood components with recommendations for donor screening, donor deferral, and product management to reduce the risk of transfusion-transmitted Zika virus. The document applies to the collection of whole blood and blood components intended for transfusion, but not to the collection of source plasma. To download this guidance, click [here](http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM486360.pdf?ref=fdaweb.com). To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-02-19/pdf/2016-03393.pdf?ref=fdaweb.com).